Contrary to previous data, which characterized NLRX1 as a tumor suppressor by inhibiting tumor promoting signaling pathways such as Akt, NF-κB or MAPK, it was also reported that NLRX1 contributes to tumorigenesis by regulating cell death. The gene discussed is AKT1; the disease is neoplasm.